|
OGT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.601200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.621400E-01 |
| Normal-vs-Stage2 |
5.392200E-01 |
| Normal-vs-Stage3 |
6.465200E-01 |
| Normal-vs-Stage4 |
9.506400E-01 |
| Stage1-vs-Stage2 |
4.435000E-01 |
| Stage1-vs-Stage3 |
8.430600E-01 |
| Stage1-vs-Stage4 |
9.595200E-01 |
| Stage2-vs-Stage3 |
4.229600E-01 |
| Stage2-vs-Stage4 |
6.655800E-01 |
| Stage3-vs-Stage4 |
9.024200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.959800E-01 |
| Normal-vs-AfricanAmerican |
3.465000E-01 |
| Normal-vs-Asian |
4.767600E-01 |
| Caucasian-vs-AfricanAmerican |
2.348800E-01 |
| Caucasian-vs-Asian |
2.501000E-01 |
| AfricanAmerican-vs-Asian |
5.506400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.612200E-01 |
| Normal-vs-Female |
2.490800E-01 |
| Male-vs-Female |
1.363580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.002800E-01 |
| Normal-vs-Extreme_Weight |
3.032600E-01 |
| Normal-vs-Obese |
5.502600E-01 |
| Normal-vs-Extreme_Obese |
9.239800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.911810E-01 |
| Normal_Weight-vs-Obese |
9.956600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.226000E-01 |
| Extreme_Weight-vs-Obese |
1.513030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.836200E-01 |
| Obese-vs-Extreme_Obese |
8.191800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.257800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.529450E-01 |
| Normal-vs-Age(61-80Yrs) |
3.634000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.781600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.534800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.280200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.675900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.753760E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.342300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.967000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.021800E-01 |
| Normal-VS-Type2 PRCC |
7.231600E-02 |
| Normal-VS-KIRP CIMP |
6.468800E-01 |
| Normal-VS-Unclassified PRCC |
3.709200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.261900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.943400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.678800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.757380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.724300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.145000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.550580E-01 |
| Normal-vs-N1 |
2.115400E-01 |
| Normal-vs-N2 |
1.094800E-01 |
| N0-vs-N1 |
6.249700E-02 |
| N0-vs-N2 |
5.273200E-01 |
| N1-vs-N2 |
2.665800E-01 |
|
|
